Image

Evaluating the Implementation of a Need-Based Cancer Survivorship Program

Evaluating the Implementation of a Need-Based Cancer Survivorship Program

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The project aims to conduct an implementation evaluation of the need-based cancer survivorship program using the RE-AIM framework.

Description

This study aims to implement the survivorship program through collaboration with NGOs and District Health Centers. The implementation of a need-based cancer survivorship program involves structured screening and needs assessment, with a focus on symptom distress and weight-related concerns. Based on identified needs, appropriate service referrals will be made to ensure timely and targeted support for cancer survivors.

The program is a prospective implementation study using both quantitative and qualitative methods, guided by the RE-AIM framework. The program plans to screen approximately 12,500 cancer survivors. The program will use the Edmonton Symptom Assessment System (ESAS) to identify symptom distress and a new diagnostic framework for weight-related concerns, with referrals made to JCICC or NGO/DHC partners for moderate-to-high needs.

Eligibility

Inclusion Criteria: (Cancer patients)

  • Chinese/English speaking adult cancer patients aged 18 years or older
  • Within three years post-treatment attending the specialized outpatient clinics for surveillance

Exclusion Criteria: (Cancer patients)

  • Non-Chinese or non-English speaking
  • Childhood cancer survivors
  • More than three years post-treatment
  • and/or unable to provide informed consent

Inclusion Criteria: (Peer volunteers)

  • Aged 18 years or older
  • Able to communicate in Chinese or English
  • Have lived experience as a cancer survivor or caregiver

Study details
    Cancer Survivorship

NCT07830368

The University of Hong Kong

20 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.